Tag: CORO
Moderna Asks FDA to Authorize Its COVID-19 Vaccine for Children Under 6
Preliminary analysis indicates vaccine efficacy of 51 percent among children younger than 2 years and 37 percent among children 2 to 5 years
Shared Genetic Variants for COVID-19 Severity, Medical Conditions ID’d
Other medical conditions have associations with the same genetic variants associated with COVID-19 severity
E.U. Says Europe Out of ‘Emergency’ Phase of Pandemic
Announcement is not binding and national governments within the European Union will still be able to set their own public health policies
Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose
In large cohort, there were 5.55 excess events per 100,000 vaccinees after BNT162b2 and 18.39 after mRNA-1273
Natural COVID-19 Immunity Produces Protection Similar to Vaccines
Similar natural protection seen against mild and severe disease
SARS-CoV-2 Seroprevalence Up From Dec. 2021 to Feb. 2022
By February 2022, seroprevalence reached 75.2 percent among children aged 0 to 11 years, 74.2 percent for teens aged 12 to 17 years
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
Initial two-dose series of the Pfizer vaccine was authorized for that age group in October
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
FDA Approves First COVID-19 Treatment for Use in Children
Veklury had already been fully approved to treat people 12 years and older
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
Many Americans have said they cannot find a doctor to prescribe Paxlovid or a pharmacy that has it
